Fresno Blood and Blood Products
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), Network Contract Office 21 (NCO 21), has issued a Notice of Intent to Sole Source for Blood and Blood Products for the Fresno VA Medical Center (VAMC). The intended awardee is the Central California Blood Center, justified by their unique FDA registration and ability to meet critical short delivery timeframes. Other responsible sources may submit capability statements and quotes by May 6, 2026, at 11:00 AM Pacific Time to be considered for a potential competitive procurement.
Purpose & Context
This procurement aims to secure a continuous supply of blood and blood products for the VA Central California Health Care System (VACCHCS) in Fresno, CA. The VA's market research indicates that the Central California Blood Center is the only entity FDA registered to store and distribute these products to the Fresno VA within the required short delivery windows, including a critical two-hour delivery for STAT orders. This justifies the intent for a sole-source award under the authority of 41 U.S.C. § 1901, implemented by FAR 12.102(b).
Scope of Work
The contract requires the provision and delivery of a comprehensive range of blood and blood products on an "AS NEEDED" basis. Key requirements include:
- Furnishing various blood components (e.g., Red Blood Cells, Platelets, Plasma, Cryoprecipitate).
- Adherence to specific collection, labeling, and quality standards (e.g., 100% volunteer donors, free of hemolysis/clots).
- Rapid delivery: two (2) hours for STAT/Emergency orders and four (4) hours for stock orders.
- Provision of current FDA licensure and AABB accreditation.
- Availability of 24/7 reference laboratory services for red cell antibody identification and plasmapheresis/cytopheresis services.
Contract Details
- Contract Type: Firm-Fixed-Price, Estimated Quantity Purchase Order.
- Period of Performance: One (1) year, from June 1, 2026, to May 31, 2027.
- NAICS Code: 621991 (Blood and Organ Banks), with a small business size standard of $40 Million.
- Product Service Code (PSC): 6506 (Blood And Blood Products).
- Set-Aside: None. This is an unrestricted sole-source acquisition to a Large Business.
Submission & Response
Any responsible source that believes it can fulfill this requirement may submit a quote for the listed items and provide documentation to support their capabilities. Responses will be considered solely for the purpose of determining whether to conduct a competitive procurement instead of the intended sole-source contract.
- Submission Deadline: Wednesday, May 6, 2026, at 11:00 AM Pacific Time.
- Submission Method: Email to Leah Smith at leah.smith@va.gov.
- The Government will not compensate for information submitted. If no capable responses are received, the VA will proceed with the sole-source acquisition.